High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study

al-Jarad, N; Strickland, B; Pearson, M C; Rubens, M B; Rudd, R M
August 1992
Thorax;Aug1992, Vol. 47 Issue 8, p645
Academic Journal
journal article
No abstract available.


Related Articles

  • Cryptogenic Fibrosing Alveolitis Predating Ulcerative Colitis. De Llano, Luis A. Pérez; Lancho, Angel; Del Cerro, J. L. Soilán; López-Rosés, Leopoldo // American Journal of Gastroenterology;Apr1996, Vol. 91 Issue 4, p822 

    Presents a letter to the editor on cryptogenic fibrosing alveolitis predating ulcerative colitis.

  • Rising mortality from cryptogenic fibrosing alveolitis. Johnston, Ian; Britton, John; Kinnear, William; Logan, Richard // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1017 

    Examines the mortality rate caused by cryptogenic fibrosing alveolitis in Great Britain. Identification of factors important in the etiology of the disease; Assessment of the validity of death certification of the disease; Treatment and management of the disease.

  • SCIENTIFIC FRONTIERS IN LUNG DISEASE.  // Thorax;Dec2001 Supp, Vol. 56, piii41 

    This article presents various studies related to scientific frontiers in lung disease. The immune pathology of sarcoidosis is characterized by an exaggerated CD4 T cell response to an undefined antigens. Spontaneous remission occurs in the majority of subjects, but 30% of patients develon...

  • Interstitial lung disease: progress and problems. Bourke, S. J. // Postgraduate Medical Journal;Aug2006, Vol. 82 Issue 970, p494 

    Interstitial lung disease involves all areas of medicine as it often occurs in patients with comorbidities or as a consequence of systemic diseases and their treatment. Typically the physician is faced with a breathless patient, a diffusely abnormal chest radiograph, and a wide differential...

  • Minerva.  // BMJ: British Medical Journal (International Edition);04/11/98, Vol. 316 Issue 7138, p1178 

    Presents information on developments in medicine. Information on injuries from snowmobiles; Account on an approach for treating metastatic breast cancer; Survival period of patients with cryptogenic fibrosing alveolitis.

  • Idiopathic Pulmonary Fibrosis: Pathogenesis and Therapeutic Approaches. Selman, Moisés; Thannickal, Victor J.; Pardo, Annie; Zisman, David A.; Martinez, Fernando J.; Lynch, III., Jose P. // Drugs;2004, Vol. 64 Issue 4, p405 

    Idiopathic pulmonary fibrosis (IPF), also termed cryptogenic fibrosing alveolitis, is a clinicopathological syndrome characterised by cough, exertional dyspneoa, basilar crackles, a restrictive defect on pulmonary function tests, honeycombing on high-resolution, thin-section computed tomographic...

  • Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Dawson, J. K.; Fewins, H. E.; Desmond, J.; Lynch, M. P.; Graham, D. R. // Thorax;Aug2001, Vol. 56 Issue 8, p622 

    Background: Fibrosing alveolitis (FA) is a common and serious complication of rheumatoid arthritis (RA). Before the availability of high resolution computed tomographic (HRCT) scanning, it was difficult to diagnose accurately without recourse to biopsy. Prospective studies have...

  • Cryptogenic fibrosing alveolitis and lung cancer: the BTS study. J M Harris // Thorax;Jan2010, Vol. 65 Issue 1, p70 

    BACKGROUND: The risk of lung cancer is often reported to be increased for patients with cryptogenic fibrosing alveolitis (CFA). METHODS: Vital status was sought for all 588 members of the British Thoracic Society (BTS) cryptogenic fibrosing alveolitis (CFA) study 11 years after entry to the...

  • A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis. Clark, M.; Cooper, B.; Singh, S.; Cooper, M.; Carr, A.; Hubbard, R. // Thorax;Jun2001, Vol. 56 Issue 6, p482 

    Background: A survey of overnight oximetry was conducted to estimate the prevalence of nocturnal hypoxaemia in patients with cryptogenic fibrosing alveolitis and to establish whether nocturnal hypoxaemia is related to quality of life. Methods: All patients with...

  • What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. Scott, Jonathan; Johnston, Ian; Britton, John // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1015 

    Examines the etiology of cryptogenic fibrosing alveolitis in Nottingham, England. Role of the occupational and domestic exposure to dust for the development of the disease; Survival of patients after a month of diagnosed; Evaluation of the restrictive pulmonary function test for the investigation.


Read the Article


Sign out of this library

Other Topics